The RAPS store will be under maintenance Saturday, 17 April between 5 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > FDAAA and the Office of New Drugs: An Interview with Dr. John Jenkins.

FDAAA and the Office of New Drugs: An Interview with Dr. John Jenkins.

Posted 01 May 2009

On 5 March, Dr. John Jenkins, director of the US Food and Drug Administration's Office of New Drugs, took the time to answer some questions on the Food and Drug Administration Amendments Act posed by the RAPS Board of Editors.

 

© 2021 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe